Overview

Role of Metabolites in Nicotine Dependence (3) - 6

Status:
Completed

Trial end date:
2001-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the effects of various doses of ondansetron transdermal nicotine replacement on tobacco withdrawal symptoms.

Phase:

Phase 2

Details

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Collaborators:

University of Minnesota
University of Minnesota - Clinical and Translational Science Institute

Treatments:

Nicotine
Ondansetron